Fund HoldingsCaligan Partners LP

Total Portfolio Value
$479.23M
Total Bought
$54.98M
Total Sold
$1.06M
Net Transaction
+$53.91M
Filing Period:
Securities
SharesValue ($K)
Q4 2024
Q1 2025
Change
Q4 2024
Q1 2025
Weight (%)
Change
VERONA PHARMA PLC1,436,8781,436,878066,72991,22719.04%+24,499
MINERALYS THERAPEUTICS INC(MLYS)1,011,1552,149,667+1,138,51212,44734,1377.12%+21,689
REVOLUTION MEDICINES INC(RVMD)0465,000+465,000016,4423.43%+16,442
SAGE THERAPEUTICS INC3,052,5383,052,538016,57524,2685.06%+7,692
EXELIXIS INC(EXEL)1,525,7301,525,730050,80756,33011.75%+5,523
MERUS N V255,000376,954+121,95410,72315,8663.31%+5,143
LIQUIDIA CORPORATION(LQDA)8,118,5928,118,5920115,528119,74924.99%+4,222
EVOLUS INC2,692,3882,731,154+38,76629,72432,8566.86%+3,132
ABIVAX SA(ABVX)752,1671,269,119+516,9525,5067,9321.66%+2,426
BIOCRYST PHARMACEUTICALS INC(BCRX)2,995,9323,107,669+111,73722,52923,3084.86%+778
REZOLUTE INC0141,309+141,30904100.09%+410
TYRA BIOSCIENCES INC(TYRA)025,000+25,00002330.05%+233
AGIOS PHARMACEUTICALS INC(AGIO)626,280701,280+75,00020,58020,5484.29%-32
ENANTA PHARMACEUTICALS INC184,8260-184,8261,0630-1,063
VERRICA PHARMACEUTICALS INC7,429,6878,992,954+1,563,2675,2013,9770.83%-1,224
ANIKA THERAPEUTICS INC1,435,1301,435,130023,62221,5704.50%-2,052
Y-MABS THERAPEUTICS INC1,767,9822,342,609+574,62713,84310,3782.17%-3,466
Page 1 of 1